AI assistant
Sending…
Sopharma AD — Earnings Release 2019
May 7, 2019
2543_rns_2019-05-07_c9ad84e1-6b32-40bf-8fab-0d1338ccb9a2.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report No. 12 / 2019 Dated May 7, 2019
NOTIFICATION
Sopharma AD (the "Company") notifies that for April 2019 the Company recorded a decrease of sales revenues of 7% compared to the same month of 2018, incl. keeping the sales for the domestic market and a decrease of 11% of export sales.
In the first four months of 2019 the revenues from sales of production decreased by 3% compared to the same period of 2018, including 15% decrease in domestic sales and 5% increase of export sales.
Signatures of individuals authorized to represent the Company:
Ognian Donev
More from Sopharma AD
Regulatory Filings
2026
May 29
Transaction in Own Shares
2026
May 29
Transaction in Own Shares
2026
May 28
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Transaction in Own Shares
2026
May 19